Document is current

Any future updates will be listed below

First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignancies

Crossref DOI link: https://doi.org/10.1007/s10637-015-0262-2

Published Online: 2015-06-17

Published Print: 2015-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark